Management changeNotableFiled on BSE ·

Veedol Corporation Limited announces MD change and approves Q2 FY2027 results

Veedol Corporation

Arthneeti Research DeskPublished 1 min read

Key highlights

  • Approved unaudited standalone and consolidated financial results for Q2 and H1 ended Sept 30, 2026, including limited review reports.
  • Shri Rajendra Nath Ghosal resigned as Managing Director effective Nov 19, 2026, re-designated as President until Mar 31, 2027.
  • Shri Rohit Ghanshyamdas Totla appointed Additional Director and Managing Director for 5 years starting Nov 20, 2026, subject to shareholder approval via postal ballot.

Why it's rated notable: No amount is stated for the Managing Director resignation and appointment, so the level stays at medium, and the new appointment remains subject to shareholder approval.

Original filing

Announcement under Regulation 30 (LODR)-Resignation of Managing Director

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Other management change filings this fortnight

All management change filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.